The Cystic Fibrosis (CF) community celebrates a landmark achievement this fall. For the first time, a highly effective medication is available to treat the underlying cause of CF for 90% of people with this life-threatening genetic disease. CF causes frequent lung infections, progressive lung disease, and malnutrition due to abnormally thick mucus in the lungs…

Read More

“The Forum on Healthcare Innovation: Technology and the Future of Healthcare Delivery” was hosted by Jackson Laboratories in Farmington, CT on the UCONN Health campus on October 25-26, 2017. The conference was full of healthcare innovators and professionals and covered genetic testing (including direct-to-consumer), genomics, the microbiome, patient advocacy and healthcare technology. Check out some…

Read More